Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

[Gene-specific treatment approaches in Alzheimer's disease and other tauopathies].

Journal article

Feneberg E. and Otto M., (2020), Nervenarzt, 91, 312 - 317

A TRIAGING BLOOD TEST FOR NEUROLOGY? SERUM NEUROFILAMENT LEVELS IN A COHORT OF GP REFERRALS

Conference paper

Robertson J. et al, (2019), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, E22 - E23

The interactome of human TDP-43 in a cellular model of amyotrophic lateral sclerosis

Conference paper

Feneberg E. et al, (2019), EUROPEAN JOURNAL OF NEUROLOGY, 26, 221 - 222

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis

Journal article

Verde F. et al, (2019), Journal of Neurology, Neurosurgery & Psychiatry, 90, 157 - 164

Hibernation Impairs Odor Discrimination - Implications for Alzheimer's Disease.

Journal article

Bullmann T. et al, (2019), Front Neuroanat, 13

Amyotrophic lateral sclerosis: the complex path to precision medicine

Journal article

Talbot K. et al, (2018), Journal of Neurology, 265, 2454 - 2462

Frontotemporale Demenz

Journal article

Otto M. et al, (2018), Der Klinikarzt, 47, 472 - 476

Towards a TDP-43-Based Biomarker for ALS and FTLD

Journal article

Feneberg E. et al, (2018), Molecular Neurobiology, 55, 7789 - 7801

Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis

Journal article

Feneberg E. et al, (2018), Neurology, 90, e22 - e30

Multivariate diagnostic approaches in Frontotemporal lobar degeneration - Data from the german FTLDc

Conference paper

Straub S. et al, (2016), JOURNAL OF NEUROCHEMISTRY, 138, 407 - 407

Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update

Journal article

Oeckl P. et al, (2016), Journal of Neurochemistry, 138, 184 - 192

Neurochemical markers in the differential diagnosis of primary progressive aphasias: Data from the German FTLD consortium

Conference paper

Oeckl P. et al, (2016), JOURNAL OF NEUROCHEMISTRY, 138, 355 - 355

Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD

Journal article

Feneberg E. et al, (2016), Journal of Neural Transmission, 123, 289 - 296

Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients

Journal article

Steinacker P. et al, (2016), Journal of Neurology, Neurosurgery & Psychiatry

Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives

Journal article

Oeckl P. et al, (2015), Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1854, 757 - 768

Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases

Journal article

Feneberg E. et al, (2014), Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15, 351 - 356

Load More